newsfilter
← Latest News
FDA Approved Drugs·

Approval of Jakafi, Nda #202192 (Labeling)

Approval Date: 07/20/2026; Drug Name: Jakafi, Nda #202192; Active Ingredients: RUXOLITINIB PHOSPHATE; Company: Incyte Corp; Submission Status: Approval; Submission Classification: Labeling; Application Number: 202192

Company
INCYTE CORP
Keywords
INCYTE CORP